Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
34 participants
INTERVENTIONAL
2021-11-05
2022-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The PulmoVista 500 is a clinical routine which provide effective non-invasive bedside measurements. It would be interesting to evaluate the impact of extubation on respiratory function, and more specifically FRC changes during and after extubation.
This study will allow a better physiopathological knowledge and a quality improvement patient extubation management.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Atelectasis by Electrical Impedance Tomography
NCT05713929
Respiratory Variability and Postoperative Complications During Thoracic Lung Resection.
NCT06133777
riSk Factors fOR neCk phlEgmon afteR pErcutaneous tRacheostomy in ICU
NCT06552676
Lung Aeration After Flexible Bronchoscopy in Intubated Critically Ill Patients
NCT05200494
Deep Sedation With Pre-emptive Endotracheal Intubation for Advanced Bronchoscopy Procedures
NCT06887335
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients with scheduled surgery and receiving general anesthesia with orotracheal intubation are included and the measurements will be performed in the post-interventional monitoring room (PICU). EELI data will be collected before extubation and then at T0, then T5, T10, T15 and T20 minutes. No subsequent follow-up is required.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Functional residual capacity
Functional residual capacity measure during and after extubation
Functional residual capacity measure by electrical impedance tomography
Patient functional residual capacity will be measured by electrical impedance tomography before extubation and then at 0, 10, 15 and 20 min after extubation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Functional residual capacity measure by electrical impedance tomography
Patient functional residual capacity will be measured by electrical impedance tomography before extubation and then at 0, 10, 15 and 20 min after extubation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient in operating room for scheduled surgery
* Patient receiving general anaesthesia with orotracheal intubation
* Patient given written consent after information
* Patient covered by social security or equivalent regimen
Exclusion Criteria
* Patient who has undergone intracerebral surgery because of possible communication difficulties upon awakening,
* Patients with a body mass index (BMI) \> 50 (measurements not possible)
* Pregnant or breastfeeding patient,
* Patient contraindicated to the use of a thoracic electroimpedancemetry technique: dressings, wounds, presence of a pacemaker, defibrillator or any other active implant.
* Patient deprived of liberty by a judicial or administrative decision or patient subject to a legal protection measure (guardianship, curatorship...)
* Patient in a period of exclusion from another research protocol
* Any other reason that, in the opinion of the investigator, could interfere with the evaluation of study objectives
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clarisse LEGER, Nurse
Role: STUDY_DIRECTOR
Hôpital d'instruction des armées Sainte-Anne
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital d'Instruction des Armées de Sainte Anne
Toulon, Var, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-A00785-36
Identifier Type: OTHER
Identifier Source: secondary_id
2020-CHITS-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.